Nasdaq: BCRX

Biocryst Pharmaceuticals Inc. (BCRX)

Biocryst Pharmaceuticals Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker BCRX. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
BCRX
Exchange
Nasdaq
SEC CIK
882796
Official filings
SEC EDGAR

Research BCRX

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Biocryst Pharmaceuticals Inc.'s stock ticker?

Biocryst Pharmaceuticals Inc. trades under the ticker symbol BCRX on Nasdaq. Its SEC Central Index Key (CIK) is 882796.

Where can I read Biocryst Pharmaceuticals Inc.'s SEC filings?

The BCRX SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Biocryst Pharmaceuticals Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze BCRX's financial statements?

The BCRX Financials page shows Biocryst Pharmaceuticals Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does BCRX compare with its peers and the market?

The BCRX Peer Comparison page lines Biocryst Pharmaceuticals Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.